Cantor Fitzgerald Reiterates Overweight Rating on Pfizer (PFE)

March 19, 2020 6:52 AM EDT Send to a Friend
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $53.00 price target on Pfizer (NYSE: PFE) following the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login